Which has better earnings and valuation, BDSX or ITGR?

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biodesix $102.94M 2.98 -$35.26M -$3.17 N/A Integer $1.85B 2.32 $102.81M $3.66 34.51

Is BDSX or ITGR more profitable?

Integer has a net margin of 6.97% compared to Biodesix's net margin of -26.97%. Integer's return on equity of 12.79% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets Biodesix -26.97% -788.19% -30.33% Integer 6.97% 12.79% 6.48%

Does the media refer more to BDSX or ITGR?

In the previous week, Biodesix had 6 more articles in the media than Integer. MarketBeat recorded 7 mentions for Biodesix and 1 mentions for Integer. Biodesix's average media sentiment score of 0.01 beat Integer's score of -0.58 indicating that Biodesix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biodesix 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Integer 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative

Which has better earnings and valuation, ITGR or ELV?

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 2.32 $102.81M $3.66 34.51 Elevance Health $199.13B 0.43 $5.66B $22.50 17.61

Does the media favor ITGR or ELV?

In the previous week, Elevance Health had 2 more articles in the media than Integer. MarketBeat recorded 3 mentions for Elevance Health and 1 mentions for Integer. Elevance Health's average media sentiment score of 1.08 beat Integer's score of -0.58 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative Elevance Health 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, ITGR or PEN?

Penumbra has lower revenue, but higher earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 2.32 $102.81M $3.66 34.51 Penumbra $1.40B 8.95 $177.69M $4.07 78.40

Is ITGR or PEN more profitable?

Penumbra has a net margin of 10.67% compared to Integer's net margin of 6.97%. Integer's return on equity of 12.79% beat Penumbra's return on equity. Company Net Margins Return on Equity Return on Assets Integer 6.97% 12.79% 6.48% Penumbra 10.67% 10.50% 8.17%

Does the media favor ITGR or PEN?

In the previous week, Integer and Integer both had 1 articles in the media. Penumbra's average media sentiment score of 0.62 beat Integer's score of -0.58 indicating that Penumbra is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative Penumbra 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ITGR or BAX?

In the previous week, Baxter International had 3 more articles in the media than Integer. MarketBeat recorded 4 mentions for Baxter International and 1 mentions for Integer. Baxter International's average media sentiment score of 0.02 beat Integer's score of -0.58 indicating that Baxter International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative Baxter International 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, SNN or ITGR?

Smith & Nephew SNATS has higher revenue and earnings than Integer. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Smith & Nephew SNATS $6.30B 1.79 $625M N/A N/A Integer $1.85B 2.32 $102.81M $3.66 34.51

Does the media refer more to SNN or ITGR?

In the previous week, Smith & Nephew SNATS had 6 more articles in the media than Integer. MarketBeat recorded 7 mentions for Smith & Nephew SNATS and 1 mentions for Integer. Smith & Nephew SNATS's average media sentiment score of 0.05 beat Integer's score of -0.58 indicating that Smith & Nephew SNATS is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew SNATS 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Integer 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative

Integer (ITGR) Competitors

$126.30 +0.13 (+0.10%)

Closing price 09/25/2026 03:59 PM Eastern

Extended Trading

$126.31 +0.02 (+0.01%)

As of 09/25/2026 07:30 PM Eastern

Compare

ITGR vs. BDSX, ELV, PEN, BAX, and SNN

Should you buy Integer stock or one of its competitors? Integer's main competitors and comparable companies include Biodesix (BDSX), Elevance Health (ELV), Penumbra (PEN), Baxter International (BAX), and Smith & Nephew SNATS (SNN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Integer compare to Biodesix?

Biodesix (NASDAQ:BDSX) and Integer (NYSE:ITGR) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

Integer has a net margin of 6.97% compared to Biodesix's net margin of -26.97%. Integer's return on equity of 12.79% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-26.97%	-788.19%	-30.33%
Integer	6.97%	12.79%	6.48%

In the previous week, Biodesix had 6 more articles in the media than Integer. MarketBeat recorded 7 mentions for Biodesix and 1 mentions for Integer. Biodesix's average media sentiment score of 0.01 beat Integer's score of -0.58 indicating that Biodesix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biodesix	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integer	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$102.94M	2.98	-$35.26M	-$3.17	N/A
Integer	$1.85B	2.32	$102.81M	$3.66	34.51

21.0% of Biodesix shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 23.2% of Biodesix shares are owned by insiders. Comparatively, 1.1% of Integer shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Biodesix has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market. Comparatively, Integer has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Biodesix currently has a consensus target price of $35.00, suggesting a potential upside of 20.27%. Integer has a consensus target price of $109.86, suggesting a potential downside of 13.02%. Given Biodesix's stronger consensus rating and higher probable upside, equities analysts clearly believe Biodesix is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

Summary

Integer beats Biodesix on 9 of the 17 factors compared between the two stocks.

How does Integer compare to Elevance Health?

Integer (NYSE:ITGR) and Elevance Health (NYSE:ELV) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

99.3% of Integer shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Integer has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.69, indicating that its share price is 31% less volatile than the broader market.

Integer currently has a consensus price target of $109.86, indicating a potential downside of 13.02%. Elevance Health has a consensus price target of $440.90, indicating a potential upside of 11.26%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts plainly believe Elevance Health is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65

Integer has a net margin of 6.97% compared to Elevance Health's net margin of 2.47%. Elevance Health's return on equity of 14.64% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Elevance Health	2.47%	14.64%	5.22%

In the previous week, Elevance Health had 2 more articles in the media than Integer. MarketBeat recorded 3 mentions for Elevance Health and 1 mentions for Integer. Elevance Health's average media sentiment score of 1.08 beat Integer's score of -0.58 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative
Elevance Health	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.32	$102.81M	$3.66	34.51
Elevance Health	$199.13B	0.43	$5.66B	$22.50	17.61

Summary

Elevance Health beats Integer on 10 of the 16 factors compared between the two stocks.

How does Integer compare to Penumbra?

Integer (NYSE:ITGR) and Penumbra (NYSE:PEN) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

Integer presently has a consensus target price of $109.86, indicating a potential downside of 13.02%. Penumbra has a consensus target price of $367.07, indicating a potential upside of 15.04%. Given Penumbra's stronger consensus rating and higher possible upside, analysts clearly believe Penumbra is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

99.3% of Integer shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 2.9% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Penumbra has a net margin of 10.67% compared to Integer's net margin of 6.97%. Integer's return on equity of 12.79% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Penumbra	10.67%	10.50%	8.17%

In the previous week, Integer and Integer both had 1 articles in the media. Penumbra's average media sentiment score of 0.62 beat Integer's score of -0.58 indicating that Penumbra is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative
Penumbra	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market.

Penumbra has lower revenue, but higher earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.32	$102.81M	$3.66	34.51
Penumbra	$1.40B	8.95	$177.69M	$4.07	78.40

Summary

Penumbra beats Integer on 12 of the 15 factors compared between the two stocks.

How does Integer compare to Baxter International?

Integer (NYSE:ITGR) and Baxter International (NYSE:BAX) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

Integer has a net margin of 6.97% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Baxter International	-9.27%	16.57%	5.24%

In the previous week, Baxter International had 3 more articles in the media than Integer. MarketBeat recorded 4 mentions for Baxter International and 1 mentions for Integer. Baxter International's average media sentiment score of 0.02 beat Integer's score of -0.58 indicating that Baxter International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative
Baxter International	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integer has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market.

Integer currently has a consensus price target of $109.86, suggesting a potential downside of 13.02%. Baxter International has a consensus price target of $22.45, suggesting a potential downside of 4.00%. Given Baxter International's higher probable upside, analysts clearly believe Baxter International is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Integer has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.32	$102.81M	$3.66	34.51
Baxter International	$11.24B	1.08	-$957M	-$2.07	N/A

99.3% of Integer shares are held by institutional investors. Comparatively, 90.2% of Baxter International shares are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 0.2% of Baxter International shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Integer beats Baxter International on 10 of the 16 factors compared between the two stocks.

How does Integer compare to Smith & Nephew SNATS?

Smith & Nephew SNATS (NYSE:SNN) and Integer (NYSE:ITGR) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk.

Smith & Nephew SNATS presently has a consensus target price of $31.91, indicating a potential upside of 18.52%. Integer has a consensus target price of $109.86, indicating a potential downside of 13.02%. Given Smith & Nephew SNATS's higher probable upside, research analysts plainly believe Smith & Nephew SNATS is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew SNATS	1 Sell rating(s)	10 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

Smith & Nephew SNATS has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market. Comparatively, Integer has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market.

In the previous week, Smith & Nephew SNATS had 6 more articles in the media than Integer. MarketBeat recorded 7 mentions for Smith & Nephew SNATS and 1 mentions for Integer. Smith & Nephew SNATS's average media sentiment score of 0.05 beat Integer's score of -0.58 indicating that Smith & Nephew SNATS is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smith & Nephew SNATS	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integer	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative

Integer has a net margin of 6.97% compared to Smith & Nephew SNATS's net margin of 0.00%. Integer's return on equity of 12.79% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew SNATS	N/A	N/A	N/A
Integer	6.97%	12.79%	6.48%

Smith & Nephew SNATS has higher revenue and earnings than Integer.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew SNATS	$6.30B	1.79	$625M	N/A	N/A
Integer	$1.85B	2.32	$102.81M	$3.66	34.51

25.6% of Smith & Nephew SNATS shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 1.0% of Smith & Nephew SNATS shares are held by insiders. Comparatively, 1.1% of Integer shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Integer beats Smith & Nephew SNATS on 8 of the 13 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ITGR vs. The Competition

Export

Metric	Integer	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$4.30B	$5.56B	$7.33B	$22.98B
Dividend Yield	N/A	1.79%	2.52%	3.68%
P/E Ratio	34.51	25.31	275.82	28.00
Price / Sales	2.32	72.45	638.64	88.74
Price / Cash	12.19	32.91	79.52	41.27
Price / Book	2.53	5.77	10.44	4.66
Net Income	$102.81M	$151.55M	$3.51B	$1.07B
7 Day Performance	-0.04%	-0.97%	-1.31%	-1.12%
1 Month Performance	0.78%	-4.40%	-4.61%	-5.10%
1 Year Performance	24.31%	7.68%	15.01%	7.73%

Integer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ITGR Integer	2.1291 of 5 stars	$126.30 +0.1%	$109.86 -13.0%	+24.3%	$4.30B	$1.85B	34.51	11,000
BDSX Biodesix	3.8691 of 5 stars	$28.94 -0.9%	$31.33 +8.3%	+275.5%	$302.99M	$88.50M	N/A	334	News Coverage Analyst Forecast
ELV Elevance Health	4.4564 of 5 stars	$409.02 -0.1%	$440.90 +7.8%	+24.6%	$88.79B	$199.13B	18.20	97,100	Positive News
PEN Penumbra	2.8023 of 5 stars	$319.19 +0.1%	$367.07 +15.0%	+25.8%	$12.57B	$1.50B	78.44	4,700
BAX Baxter International	1.0833 of 5 stars	$23.57 +2.8%	$22.45 -4.7%	+6.6%	$12.22B	$11.24B	N/A	37,500

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ITGR) was last updated on 9/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integer (ITGR) Competitors

ITGR vs. BDSX, ELV, PEN, BAX, and SNN

How does Integer compare to Biodesix?

Summary

How does Integer compare to Elevance Health?

Summary

How does Integer compare to Penumbra?

Summary

How does Integer compare to Baxter International?

Summary

How does Integer compare to Smith & Nephew SNATS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITGR vs. The Competition

Integer Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integer (ITGR) Competitors

ITGR vs. BDSX, ELV, PEN, BAX, and SNN

How does Integer compare to Biodesix?

Is BDSX or ITGR more profitable?

Does the media refer more to BDSX or ITGR?

Which has better earnings and valuation, BDSX or ITGR?

Do institutionals and insiders have more ownership in BDSX or ITGR?

Which has more volatility and risk, BDSX or ITGR?

Do analysts prefer BDSX or ITGR?

Summary

How does Integer compare to Elevance Health?

Do institutionals & insiders believe in ITGR or ELV?

Which has more volatility & risk, ITGR or ELV?

Do analysts prefer ITGR or ELV?

Is ITGR or ELV more profitable?

Does the media favor ITGR or ELV?

Which has better earnings and valuation, ITGR or ELV?

Summary

How does Integer compare to Penumbra?

Do analysts prefer ITGR or PEN?

Do institutionals and insiders believe in ITGR or PEN?

Is ITGR or PEN more profitable?

Does the media favor ITGR or PEN?

Which has more risk and volatility, ITGR or PEN?

Which has higher valuation and earnings, ITGR or PEN?

Summary

How does Integer compare to Baxter International?

Is ITGR or BAX more profitable?

Does the media prefer ITGR or BAX?

Which has more volatility and risk, ITGR or BAX?

Do analysts prefer ITGR or BAX?

Which has better valuation & earnings, ITGR or BAX?

Do insiders and institutionals have more ownership in ITGR or BAX?

Summary

How does Integer compare to Smith & Nephew SNATS?

Do analysts prefer SNN or ITGR?

Which has more volatility & risk, SNN or ITGR?

Does the media refer more to SNN or ITGR?

Is SNN or ITGR more profitable?

Which has stronger valuation & earnings, SNN or ITGR?

Do insiders & institutionals have more ownership in SNN or ITGR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITGR vs. The Competition

Integer Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools